Oral Clinical Nutrition Supplements Market- Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032
Description
Market Overview:
The Oral Clinical Nutrition Supplements Market is projected to grow from USD 10,795 million in 2024 to USD 17,205.58 million by 2032, reflecting a compound annual growth rate (CAGR) of 6%.
This market has witnessed steady growth driven by the increasing recognition of the importance of proper nutrition in managing various health conditions. Key factors fueling market expansion include the rising prevalence of chronic diseases, an aging global population, and heightened awareness of the role nutrition plays in managing health. Oral clinical nutrition supplements have become integral to healthcare, particularly for individuals dealing with chronic conditions such as diabetes, cancer, and malnutrition. These supplements are also essential for patients recovering from illness or surgery. The rising demand for personalized nutrition solutions tailored to individual health needs is further driving market growth. Additionally, innovations in product formulations, including medical-grade oral nutrition supplements, and the growing popularity of plant-based and gluten-free options are contributing to the market’s upward trajectory.
Market Drivers:
Aging Population and Increased Healthcare Needs:
One of the most significant drivers of the Oral Clinical Nutrition Supplements market is the aging global population. As people age, they encounter numerous nutritional challenges such as reduced appetite, nutrient absorption issues, and chronic health conditions. According to a 2023 report from the World Health Organization (WHO), nearly 1 in 6 people globally will be aged 60 years or older by 2030, emphasizing the increasing need for specialized nutrition support. Older adults are more likely to experience conditions like malnutrition, osteoporosis, and frailty, all of which benefit from proper nutritional intervention. Oral clinical nutrition supplements offer an effective solution to these issues, making them an essential component of elderly healthcare. As the proportion of older adults increases in both developed and developing regions, this demographic is significantly contributing to the market’s growth.
Market Challenges:
High Costs and Accessibility:
A key challenge in the Oral Clinical Nutrition Supplements market is the high cost associated with specialized nutrition products. Clinical nutrition supplements, particularly those designed for specific medical conditions, are often priced at a premium. This can limit accessibility for patients, particularly in low-income regions or among individuals without sufficient healthcare coverage. While these supplements are vital for managing certain health conditions, the financial burden may deter widespread adoption, leading to gaps in access to critical nutritional support, especially for vulnerable populations. Addressing these accessibility issues will be crucial for the market’s continued growth.
Segmentation:
By Product Type:
Specialized Formula
Standard Formula
By Form:
Semi-solid
Powder
Liquid
By Indication:
IBD & GI Tract Disorders
Neurological Disorders
Respiratory Disorders
General Well-being
Diabetes
Dysphagia
Renal Disorders
Hepatic Disorders
Oncology Nutrition
Others
By End User:
Geriatric
Adult
Pediatric
By Flavor:
Flavored
Regular
Orange
Nut Flavors
Chocolate
Apple
Mixed Berries
Vanilla
Strawberry
By Region:
Europe
North America
Latin America
East Asia
The Middle East and Africa
By Channel:
Prescription-based
Over-the-Counter
Drug Stores
Online Pharmacies
Hospital Pharmacies
Modern Trade
Retail Pharmacies
Key Players:
NUTRICIÓN MÉDICA SL
Meiji Holdings Co., Ltd.
Medtrition Inc.
Baxter International Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Mead Johnson & Company, LLC
Otsuka Holdings Co., Ltd.
Abbott Laboratories
Danone Nutricia
Victus, Inc.
Cambrooke Therapeutics, Inc.
The Oral Clinical Nutrition Supplements Market is projected to grow from USD 10,795 million in 2024 to USD 17,205.58 million by 2032, reflecting a compound annual growth rate (CAGR) of 6%.
This market has witnessed steady growth driven by the increasing recognition of the importance of proper nutrition in managing various health conditions. Key factors fueling market expansion include the rising prevalence of chronic diseases, an aging global population, and heightened awareness of the role nutrition plays in managing health. Oral clinical nutrition supplements have become integral to healthcare, particularly for individuals dealing with chronic conditions such as diabetes, cancer, and malnutrition. These supplements are also essential for patients recovering from illness or surgery. The rising demand for personalized nutrition solutions tailored to individual health needs is further driving market growth. Additionally, innovations in product formulations, including medical-grade oral nutrition supplements, and the growing popularity of plant-based and gluten-free options are contributing to the market’s upward trajectory.
Market Drivers:
Aging Population and Increased Healthcare Needs:
One of the most significant drivers of the Oral Clinical Nutrition Supplements market is the aging global population. As people age, they encounter numerous nutritional challenges such as reduced appetite, nutrient absorption issues, and chronic health conditions. According to a 2023 report from the World Health Organization (WHO), nearly 1 in 6 people globally will be aged 60 years or older by 2030, emphasizing the increasing need for specialized nutrition support. Older adults are more likely to experience conditions like malnutrition, osteoporosis, and frailty, all of which benefit from proper nutritional intervention. Oral clinical nutrition supplements offer an effective solution to these issues, making them an essential component of elderly healthcare. As the proportion of older adults increases in both developed and developing regions, this demographic is significantly contributing to the market’s growth.
Market Challenges:
High Costs and Accessibility:
A key challenge in the Oral Clinical Nutrition Supplements market is the high cost associated with specialized nutrition products. Clinical nutrition supplements, particularly those designed for specific medical conditions, are often priced at a premium. This can limit accessibility for patients, particularly in low-income regions or among individuals without sufficient healthcare coverage. While these supplements are vital for managing certain health conditions, the financial burden may deter widespread adoption, leading to gaps in access to critical nutritional support, especially for vulnerable populations. Addressing these accessibility issues will be crucial for the market’s continued growth.
Segmentation:
By Product Type:
Specialized Formula
Standard Formula
By Form:
Semi-solid
Powder
Liquid
By Indication:
IBD & GI Tract Disorders
Neurological Disorders
Respiratory Disorders
General Well-being
Diabetes
Dysphagia
Renal Disorders
Hepatic Disorders
Oncology Nutrition
Others
By End User:
Geriatric
Adult
Pediatric
By Flavor:
Flavored
Regular
Orange
Nut Flavors
Chocolate
Apple
Mixed Berries
Vanilla
Strawberry
By Region:
Europe
North America
Latin America
East Asia
The Middle East and Africa
By Channel:
Prescription-based
Over-the-Counter
Drug Stores
Online Pharmacies
Hospital Pharmacies
Modern Trade
Retail Pharmacies
Key Players:
NUTRICIÓN MÉDICA SL
Meiji Holdings Co., Ltd.
Medtrition Inc.
Baxter International Inc.
B. Braun Melsungen AG
Fresenius Kabi AG
Mead Johnson & Company, LLC
Otsuka Holdings Co., Ltd.
Abbott Laboratories
Danone Nutricia
Victus, Inc.
Cambrooke Therapeutics, Inc.
Table of Contents
192 Pages
- CHAPTER NO. 1 : INTRODUCTION
- 1.1.1. Report Description
- Purpose of the Report
- USP & Key Offerings
- 1.1.2. Key Benefits for Stakeholders
- 1.1.3. Target Audience
- 1.1.4. Report Scope
- CHAPTER NO. 2 : EXECUTIVE SUMMARY
- 2.1. [Oral Clinical Nutrition Supplements Market] Snapshot
- 2.1.1. [Oral Clinical Nutrition Supplements Market], 2018 - 2032 (USD Million)
- CHAPTER NO. 3 : [Oral Clinical Nutrition Supplements Market] – INDUSTRY ANALYSIS
- 3.1. Introduction
- 3.2. Market Drivers
- 3.3. Market Restraints
- 3.4. Market Opportunities
- 3.5. Porter’s Five Forces Analysis
- CHAPTER NO. 4 : ANALYSIS COMPETITIVE LANDSCAPE
- 4.1. Company Market Share Analysis – 2023
- 4.2. [Oral Clinical Nutrition Supplements Market] Company Revenue Market Share, 2023
- 4.3. Company Assessment Metrics, 2023
- 4.4. Start-ups /SMEs Assessment Metrics, 2023
- 4.5. Strategic Developments
- 4.6. Key Players Product Matrix
- CHAPTER NO. 5 : PESTEL & ADJACENT MARKET ANALYSIS
- CHAPTER NO. 6 : [Oral Clinical Nutrition Supplements Market] – BASED ON [Product Type] ANALYSIS
- CHAPTER NO. 7 : [Oral Clinical Nutrition Supplements Market] – BASED ON [Form] ANALYSIS
- CHAPTER NO. 8 : [Oral Clinical Nutrition Supplements Market] – BASED ON [Indication] ANALYSIS
- CHAPTER NO. 9 : [Oral Clinical Nutrition Supplements Market] – BASED ON [End User] ANALYSIS
- CHAPTER NO. 10 : [Oral Clinical Nutrition Supplements Market] – BASED ON [Flavor] ANALYSIS
- CHAPTER NO. 11 : [Oral Clinical Nutrition Supplements Market] – BASED ON [By Region] ANALYSIS
- CHAPTER NO. 12 : COMPANY PROFILES
- 12.1. NUTRICIÓN MÉDICA SL
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio
- 12.1.3. SWOT Analysis
- 12.1.4. Business Strategy
- 12.1.5. Financial Overview
- 12.2. Meiji Holdings Co., Ltd.
- 12.3. Medtrition Inc.
- 12.4. Baxter International Inc.
- 12.5. B. Braun Melsungen AG.
- 12.6. Fresenius Kabi AG
- 12.7. Mead Johnson & Company, LLC
- 12.8. Otsuka Holdings Co., Ltd.
- 12.9. Abbott Laboratories
- 12.10. Danone Nutricia
- 12.11. Victus, Inc.
- 12.12. Cambrooke Therapeutics, Inc.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
